Project Grant HT94252310513
Award Date 6/1/23
Completion Date 5/31/26
Dollars Obligated $843K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
- The U.S. Department of Defense's Defense Health Agency awarded a $481,749 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will support research to dissect the spatial molecular architecture of the transformed cutaneous T cell lymphoma tumor microenvironment, with the goal of identifying novel...
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $798,673 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, with an ultimate completion date of June 14, 2029. The award funds research to characterize the role of aberrant FGD1 splicing in brain and bone metastasis in clear cell renal cell carcinoma. This research aims to advance understanding of metastatic mechanisms...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $2,837,644 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The funding will support "Translational Studies for Targeted Alpha-Particle Therapy for Rare Melanomas" over a 4-year period from September 1, 2023 to August 31, 2027. This project grant aims to advance research into innovative cancer therapies, specifically exploring...
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $2.1M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period June 1, 2026 through May 31, 2029. The award supports research focused on targeting age-driven metastatic vulnerabilities in triple-negative breast cancer, a critical health priority within the DHA's portfolio of biomedical research initiatives. As a National Cancer...
- This $697,590 federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development program) supports research at the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) to evaluate B-T cell cross-talk within tertiary lymphoid structures in melanoma progression and immune checkpoint blockade. The grant, with a performance period from July 1, 2024 to June 30, 2027, aims to advance scientific understanding of...
- Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $1,124,896 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, for a four-year performance period concluding July 14, 2029. The award funds research characterizing the role of aberrant FGD1 (FYVE, RhoGEF and PH Domains-containing Protein 1) splicing in brain and bone metastasis in clear cell renal cell...
- Federal Project Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $397,788 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026 through May 31, 2029. The award supports research activities focused on "Targeting Age-Driven Metastatic Vulnerabilities in Triple-Negative Breast Cancer," to be conducted at the center's Tampa, Florida location....
- This Project Grant award of $1,221,625.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to develop novel genetic mouse models for studying the progression and metastasis of uveal melanoma. The award period runs from June 1, 2024 to May 31, 2027. Moffitt Cancer Center is a prominent National Cancer Institute-designated comprehensive cancer center...
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $968,875 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. The award funds research to identify and assess immunotherapy targets in neurofibromatosis type 2 (NF2)-associated schwannomatosis, a rare genetic disorder characterized by the development of multiple...
- This Project Grant award, totaling $328,574.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The funding supports a 3-year research project to quantify the spatial properties of immunosuppressive macrophages in papillary renal cell carcinoma. The research aims to advance the understanding of cancer biology and immunotherapy, with...